×
-0.090909090909091 -0.181818181818182 -0.186363636363636 -0.227272727272727 -0.268181818181818 -0.227318181818182 -0.231818181818182 -0.231818181818182
Stock impact report

Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases

Ophthotech Corp (OPHT)  More Company Research Source: Business Wire
Last ophthotech corp earnings: 2/26 07:15 am Check Earnings Report
US:NASDAQ Investor Relations: investors.ophthotech.com/investor-relations
PDF NEW YORK--(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ: OPHT) announced today that the Company has converted its option and entered into an exclusive global license agreement with the University of Pennsylvania (Penn), including the Perelman School of Medicine at the University of Pennsylvania and the University of Pennsylvania School of Veterinary Medicine, and the University of Florida Research Foundation (UFRF) for rights to develop and commercialize novel adeno-associated virus (AAV) gene therapy product candidates for the treatment of Best vitelliform macular dystrophy, also known as Best disease and other bestrophinopathies, which are diseases related to mutations to the BEST1 gene. Best disease, which generally affects individuals in both eyes, is an orphan inherited retinal disease. In October 2018, Ophthotech entered into an exclusive option agreement with Penn and UFRF for rights to ne [Read more]
Impact snapshot Event time: OPHT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
OPHT alerts
from News Quantified
Opt-in for
OPHT alerts

from News Quantified
Opt-in for
OPHT alerts

from News Quantified